This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erdile, L F Articles by Mays, J P Search for Related Content PubMed PubMed Citation Articles by Erdile, L F Articles by Mays, J P

Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.

Connaught Laboratories, Inc., Swiftwater, Pennsylvania 18370.

ABSTRACT

OspA is a protective antigen of the Lyme disease spirochete Borrelia burgdorferi. Expression of the full-length B. burgdorferi B31 OspA gene in Escherichia coli produces a protein that is processed posttranslationally by signal peptidase II and contains an attached lipid moiety. The recombinant OspA lipoprotein has been purified by detergent extraction and ion-exchange chromatography. Priming and boosting with OspA lipoprotein, either with no adjuvant or adsorbed to alum, elicited a strong, dose-dependent immunoglobulin G response. Serum from vaccinated mice inhibited spirochetal growth in vitro. Mice immunized twice with as little as 0.4 micrograms of OspA lipoprotein were protected against an intradermal challenge with 10(4) infectious spirochetes. The ability of the purified recombinant lipoprotein to induce a strong protective response in the absence of toxic adjuvants makes it an excellent candidate antigen for a human vaccine against Lyme disease. By contrast, no serum immunoglobulin G or growth inhibitory response to OspA nonlipoprotein was seen at any dose. The difference in immunogenicities of the lipoprotein and nonlipoprotein forms of OspA is not due to any difference in the antigenicities of the two proteins. These results suggest that posttranslational lipid attachment is a critical determinant of the immunogenicity of the OspA protein.

This article has been cited by other articles:

• Rupprecht, T. A., Kirschning, C. J., Popp, B., Kastenbauer, S., Fingerle, V., Pfister, H.-W., Koedel, U. (2007). Borrelia garinii Induces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2. Infect. Immun. 75: 4351-4356 [Abstract] [Full Text]  
• Neff, L., Daher, S., Muzzin, P., Spenato, U., Gulacar, F., Gabay, C., Bas, S. (2007). Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein. J. Bacteriol. 189: 4739-4748 [Abstract] [Full Text]  
• Adlowitz, D. G., Sethi, S., Cullen, P., Adler, B., Murphy, T. F. (2005). Human Antibody Response to Outer Membrane Protein G1a, a Lipoprotein of Moraxella catarrhalis. Infect. Immun. 73: 6601-6607 [Abstract] [Full Text]  
• Verjan, N., Hirono, I., Aoki, T. (2005). Genetic Loci of Major Antigenic Protein Genes of Edwardsiella tarda. Appl. Environ. Microbiol. 71: 5654-5658 [Abstract] [Full Text]  
• Hovav, A.-H., Fishman, Y., Bercovier, H. (2005). Gamma Interferon and Monophosphoryl Lipid A-Trehalose Dicorynomycolate Are Efficient Adjuvants for Mycobacterium tuberculosis Multivalent Acellular Vaccine. Infect. Immun. 73: 250-257 [Abstract] [Full Text]  
• Yoder, A., Wang, X., Ma, Y., Philipp, M. T., Heilbrun, M., Weis, J. H., Kirschning, C. J., Wooten, R. M., Weis, J. J. (2003). Tripalmitoyl-S-Glyceryl-Cysteine-Dependent OspA Vaccination of Toll-Like Receptor 2-Deficient Mice Results in Effective Protection from Borrelia burgdorferi Challenge. Infect. Immun. 71: 3894-3900 [Abstract] [Full Text]  
• Cote-Sierra, J., Bredan, A., Toldos, C. M., Stijlemans, B., Brys, L., Cornelis, P., Segovia, M., de Baetselier, P., Revets, H. (2002). Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania major. Infect. Immun. 70: 240-248 [Abstract] [Full Text]  
• Matsunaga, J., Young, T. A., Barnett, J. K., Barnett, D., Bolin, C. A., Haake, D. A. (2002). Novel 45-Kilodalton Leptospiral Protein That Is Processed to a 31-Kilodalton Growth-Phase-Regulated Peripheral Membrane Protein. Infect. Immun. 70: 323-334 [Abstract] [Full Text]  
• Wooten, R. M., Ma, Y., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J. (2002). Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferi. J. Immunol. 168: 348-355 [Abstract] [Full Text]  
• Neilsen, P. O., Zimmerman, G. A., McIntyre, T. M. (2001). Escherichia coli Braun Lipoprotein Induces a Lipopolysaccharide-Like Endotoxic Response from Primary Human Endothelial Cells. J. Immunol. 167: 5231-5239 [Abstract] [Full Text]  
• Guerreiro, H., Croda, J., Flannery, B., Mazel, M., Matsunaga, J., Reis, M. G., Levett, P. N., Ko, A. I., Haake, D. A. (2001). Leptospiral Proteins Recognized during the Humoral Immune Response to Leptospirosis in Humans. Infect. Immun. 69: 4958-4968 [Abstract] [Full Text]  
• Remington, M. C., Munson, E. L., Callister, S. M., Molitor, M. L., Christopherson, J. A., DeCoster, D. J., Lovrich, S. D., Schell, R. F. (2001). Interleukin-6 Enhances Production of Anti-OspC Immunoglobulin G2b Borreliacidal Antibody. Infect. Immun. 69: 4268-4275 [Abstract] [Full Text]  
• Haake, D. A. (2000). Spirochaetal lipoproteins and pathogenesis. Microbiology 146: 1491-1504 [Full Text]  
• Keenan, J., Oliaro, J., Domigan, N., Potter, H., Aitken, G., Allardyce, R., Roake, J. (2000). Immune Response to an 18-Kilodalton Outer Membrane Antigen Identifies Lipoprotein 20 as a Helicobacter pylori Vaccine Candidate. Infect. Immun. 68: 3337-3343 [Abstract] [Full Text]  
• Thanassi, W. T., Schoen, R. T. (2000). The Lyme Disease Vaccine: Conception, Development, and Implementation. ANN INTERN MED 132: 661-668 [Abstract] [Full Text]  
• Schwan, T. G., Piesman, J. (2000). Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice. J. Clin. Microbiol. 38: 382-388 [Abstract] [Full Text]  
• Haake, D. A., Mazel, M. K., McCoy, A. M., Milward, F., Chao, G., Matsunaga, J., Wagar, E. A. (1999). Leptospiral Outer Membrane Proteins OmpL1 and LipL41 Exhibit Synergistic Immunoprotection. Infect. Immun. 67: 6572-6582 [Abstract] [Full Text]  
• Hirschfeld, M., Kirschning, C. J., Schwandner, R., Wesche, H., Weis, J. H., Wooten, R. M., Weis, J. J. (1999). Cutting Edge: Inflammatory Signaling by Borrelia burgdorferi Lipoproteins Is Mediated by Toll-Like Receptor 2. J. Immunol. 163: 2382-2386 [Abstract] [Full Text]  
• Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., Evans, J., Malawista, S. E., Molloy, P. J., Seidner, A. L., Sabetta, J. R., Simon, H. J., Klempner, M. S., Mays, J., Marks, D. (1998). A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease. NEJM 339: 216-222 [Abstract] [Full Text]  
• Wooten, R. M., Morrison, T. B., Weis, J. H., Wright, S. D., Thieringer, R., Weis, J. J. (1998). The Role of CD14 in Signaling Mediated by Outer Membrane Lipoproteins of Borrelia burgdorferi. J. Immunol. 160: 5485-5492 [Abstract] [Full Text]  
• Hanson, M. S., Cassatt, D. R., Guo, B. P., Patel, N. K., McCarthy, M. P., Dorward, D. W., Hook, M. (1998). Active and Passive Immunity against Borrelia burgdorferi Decorin Binding Protein A (DbpA) Protects against Infection. Infect. Immun. 66: 2143-2153 [Abstract] [Full Text]  
• Barbour, A., Fish, D (1993). The biological and social phenomenon of Lyme disease. Science 260: 1610-1616 [Abstract]  
• Zuckert, W. R., Kerentseva, T. A., Lawson, C. L., Barbour, A. G. (2001). Structural Conservation of Neurotropism-associated VspA within the Variable Borrelia Vsp-OspC Lipoprotein Family. J. Biol. Chem. 276: 457-463 [Abstract] [Full Text]